UNIVEST FINANCIAL Corp Makes New $12.96 Million Investment in Axon Enterprise, Inc $AXON

UNIVEST FINANCIAL Corp acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 30,675 shares of the biotechnology company’s stock, valued at approximately $12,961,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock worth $119,724,905,000 after purchasing an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in shares of Axon Enterprise by 18,050.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after purchasing an additional 13,127,348 shares during the period. Robeco Institutional Asset Management B.V. raised its stake in shares of Axon Enterprise by 391,214.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock valued at $2,952,943,000 after purchasing an additional 6,987,098 shares during the period. Assenagon Asset Management S.A. raised its stake in shares of Axon Enterprise by 5,022.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company’s stock valued at $1,802,719,000 after purchasing an additional 4,183,302 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Axon Enterprise by 8,432.6% in the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after purchasing an additional 3,496,493 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Up 4.3%

Axon Enterprise stock opened at $315.42 on Thursday. The company has a market cap of $25.68 billion, a P/E ratio of 101.10, a price-to-earnings-growth ratio of 5.75 and a beta of 1.48. Axon Enterprise, Inc has a 1-year low of $291.45 and a 1-year high of $665.07. The company has a fifty day simple moving average of $426.24 and a 200 day simple moving average of $470.65. The company has a current ratio of 3.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.76.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.87%. The business had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. During the same quarter in the previous year, the firm posted $1.17 earnings per share. The firm’s quarterly revenue was up 27.8% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Recent Axon Enterprise Headlines

Here are a few of the latest headlines about AXON:

• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Neutral Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will distribute its products to U.S. public-safety customers. The deal could broaden Axon’s offering, but its sizeable cost makes the investment a factor for investors to weigh. Axon invests $1.2B into Skydio and becomes its U.S. public safety distributor
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

Analysts Set New Price Targets

Several research analysts have recently weighed in on AXON shares. Royal Bank Of Canada reduced their price objective on Axon Enterprise from $735.00 to $615.00 and set an “outperform” rating for the company in a research report on Friday, November 6th. Barclays decreased their price objective on Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating for the company in a report on Monday. Raymond James Financial set a $675.00 target price on Axon Enterprise in a research report on Thursday, October 15th. Northcoast Research boosted their target price on Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a research note on Tuesday, August 11th. Finally, Piper Sandler restated an “overweight” rating and issued a $540.00 target price (down from $561.00) on shares of Axon Enterprise in a research note on Friday, November 6th. Thirteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average price target of $612.18.

Insider Buying and Selling at Axon Enterprise

In other news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the transaction, the insider owned 56,264 shares in the company, valued at $27,032,038.80. This trade represents a 1.78% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey Kunins sold 9,605 shares of Axon Enterprise stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total value of $6,019,453.50. Following the completion of the sale, the insider directly owned 97,761 shares in the company, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 37,397 shares of company stock valued at $21,234,034. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.